The nucleoprotein is required for lymphocytic choriomeningitis virus-based vaccine vector immunogenicity

Journal of Virology

Volumn 89, Issue 22, 2015, Pages 11734-11738

  Darbre, Stephanie ^a   Johnson, Susan ^a   Kallert, Sandra ^a,b   Lambert, Paul Henri ^a   Siegrist, Claire Anne ^a   Pinschewer, Daniel D ^a,b  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEOPROTEIN; VIRUS VACCINE; VIRUS VECTOR; 3' UNTRANSLATED REGION;

ARTICLE; CD8+ T LYMPHOCYTE; DRUG EFFICACY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENE REPLICATION; GENETIC TRANSCRIPTION; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOMODULATION; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; NONHUMAN; PRIORITY JOURNAL; TRANSGENE; VIRUS PARTICLE; VIRUS TITRATION; 3' UNTRANSLATED REGION; ANIMAL; BIOSYNTHESIS; CELL LINE; GENE EXPRESSION; GENETICS; HAMSTER; IMMUNOLOGY; MOUSE; TRANSGENIC MOUSE;

3' UNTRANSLATED REGIONS; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CRICETINAE; GENE EXPRESSION; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICE, TRANSGENIC; NUCLEOPROTEINS; VIRAL VACCINES;

EID: 84945964270     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01613-15     Document Type: Article

References (18)

1. Buchmeier MJ, Bowen MD, Peters CJ. 2001. Arenaviridae: the viruses and their replication, p 1635-1668. In Knipe D, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 4th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
2. Lee KJ, Novella IS, Teng MN, Oldstone MB, de La Torre JC. 2000. NP and L proteins of lymphocytic choriomeningitis virus (LCMV) are sufficient for efficient transcription and replication of LCMV genomic RNA analogs. J Virol 74:3470-3477. http://dx.doi.org/10.1128/JVI.74.8.3470-3477.2000.
3. Lee KJ, Perez M, Pinschewer DD, de la Torre JC. 2002. Identification of the lymphocytic choriomeningitis virus (LCMV) proteins required to rescue LCMV RNA analogs into LCMV-like particles. J Virol 76:6393-6397. http://dx.doi.org/10.1128/JVI.76.12.6393-6397.2002.
4. Flatz L, Hegazy AN, Bergthaler A, Verschoor A, Claus C, Fernandez M, Gattinoni L, Johnson S, Kreppel F, Kochanek S, Broek M, Radbruch A, Levy F, Lambert PH, Siegrist CA, Restifo NP, Lohning M, Ochsenbein AF, Nabel GJ, Pinschewer DD. 2010. Development of replicationdefective lymphocytic choriomeningitis virus vectors for the induction of potent CD8(+) T cell immunity. Nat Med 16:339-345. http://dx.doi.org/10.1038/nm.2104.
5. Roychoudhuri R, Lefebvre F, Honda M, Pan L, Ji Y, KlebanoffCA, Nichols CN, Fourati S, Hegazy AN, Goulet JP, Gattinoni L, Nabel GJ, Gilliet M, Cameron M, Restifo NP, Sekaly RP, Flatz L. 2015. Transcriptional profiles reveal a stepwise developmental program of memory CD8(+) T cell differentiation. Vaccine 33:914-923. http://dx.doi.org/10.1016/j.vaccine.2014.10.007.
6. Flatz L, Cheng C, Wang L, Foulds KE, Ko SY, Kong WP, Roychoudhuri R, Shi W, Bao S, Todd JP, Asmal M, Shen L, Donaldson M, Schmidt SD, Gall JG, Pinschewer DD, Letvin NL, Rao S, Mascola JR, Roederer M, Nabel GJ. 2012. Gene-based vaccination with a mismatched envelope protects against simian immunodeficiency virus infection in nonhuman primates. J Virol 86:7760-7770. http://dx.doi.org/10.1128/JVI.00599-12.
7. Robinson HL, Amara RR. 2005. T cell vaccines for microbial infections. Nat Med 11:S25-S32. http://dx.doi.org/10.1038/nm1212.
8. Walker JM, Raue HP, Slifka MK. 2012. Characterization of CD8+ T cell function and immunodominance generated with an H2O2-inactivated whole-virus vaccine. J Virol 86:13735-13744. http://dx.doi.org/10.1128/JVI.02178-12.
9. Amanna IJ, Raue HP, Slifka MK. 2012. Development of a new hydrogen peroxide-based vaccine platform. Nat Med 18:974-979. http://dx.doi.org/10.1038/nm.2763.
10. Pinto AK, Richner JM, Poore EA, Patil PP, Amanna IJ, Slifka MK, Diamond MS. 2013. A hydrogen peroxide-inactivated virus vaccine elicits humoral and cellular immunity and protects against lethal West Nile virus infection in aged mice. J Virol 87:1926-1936. http://dx.doi.org/10.1128/JVI.02903-12.
11. Flatz L, Bergthaler A, de la Torre JC, Pinschewer DD. 2006. Recovery of an arenavirus entirely from RNA polymerase I/II-driven cDNA. Proc Natl Acad Sci U S A 103:4663-4668. http://dx.doi.org/10.1073/pnas.0600652103.
12. Emonet SF, Garidou L, McGavern DB, de la Torre JC. 2009. Generation of recombinant lymphocytic choriomeningitis viruses with trisegmented genomes stably expressing two additional genes of interest. Proc Natl Acad Sci U S A 106:3473-3478. http://dx.doi.org/10.1073/pnas.0900088106.
13. Schildknecht A, Welti S, Geuking MB, Hangartner L, van den Broek M. 2008. Absence of CTL responses to early viral antigens facilitates viral persistence. J Immunol 180:3113-3121. http://dx.doi.org/10.4049/jimmunol.180.5.3113.
14. Kotturi MF, Peters B, Buendia-Laysa F, Jr, Sidney J, OseroffC, Botten J, Grey H, Buchmeier MJ, Sette A. 2007. The CD8+ T-cell response to lymphocytic choriomeningitis virus involves the L antigen: uncovering new tricks for an old virus. J Virol 81:4928-4940. http://dx.doi.org/10.1128/JVI.02632-06.
15. Lau LL, Jamieson BD, Somasundaram T, Ahmed R. 1994. Cytotoxic T-cell memory without antigen. Nature 369:648-652. http://dx.doi.org/10.1038/369648a0.
16. Quinn KM, Zak DE, Costa A, Yamamoto A, Kastenmuller K, Hill BJ, Lynn GM, Darrah PA, Lindsay RW, Wang L, Cheng C, Nicosia A, Folgori A, Colloca S, Cortese R, Gostick E, Price DA, Gall JG, Roederer M, Aderem A, Seder RA. 2015. Antigen expression determines adenoviral vaccine potency independent of IFN and STING signaling. J Clin Invest 125:1129-1146. http://dx.doi.org/10.1172/JCI78280.
17. Weber EL, Buchmeier MJ. 1988. Fine mapping of a peptide sequence containing an antigenic site conserved among arenaviruses. Virology 164: 30-38. http://dx.doi.org/10.1016/0042-6822(88)90616-2.
18. Battegay M, Cooper S, Althage A, Banziger J, Hengartner H, Zinkernagel RM. 1991. Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24-or 96-well plates. J Virol Methods 33:191-198. http://dx.doi.org/10.1016/0166-0934(91)90018-U.